Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-003967
Filing Date
2009-01-20
Accepted
2009-01-20 19:17:13
Documents
2
Period of Report
2009-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4265
2 POA DOCUMENT poa.txt EX-24.4_270266 2787
  Complete submission text file 0001209191-09-003967.txt   8812
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 508-767-3861
Samarsky Dmitry (Reporting) CIK: 0001426084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 09535563